Longitude Capital
Biotech Investor · 5 portfolio companies
Portfolio
5
Combined Value
$10.7B
Focus Areas
11
Top Stage
Phase 3
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| CG Oncology | $6.1B |
| Veradermics | $4.6B |
| OrsoBio | — |
| Helicore Biopharma | — |
| Follica | — |